| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/02/2004 | WO2004073492A2 Chlamydia pneumoniae associated chronic intraocular disorders and treatment thereof |
| 09/02/2004 | WO2004073486A2 Diagnostic device and method |
| 09/02/2004 | WO2004061422A3 Bindingzyme arrays and high-throughput proteomic methods |
| 09/02/2004 | WO2004059278A8 Methods of screening for anti-inflammatory drugs and use thereof |
| 09/02/2004 | WO2004052302A3 A method for creating specific, high affinity nuclear receptor pharmaceuticals |
| 09/02/2004 | WO2004051221A3 Measurement of total reactive isocyanate groups in samples using bifunctional nucleophiles such as 1,8-diaminonaphthalene (dan) |
| 09/02/2004 | WO2004048978A3 Diagnostics and therapeutics for diseases associated with bile acid g-protein-coupled receptor 37 (bg37) |
| 09/02/2004 | WO2004046730A3 Uses of ble proteins and antibiotics from the bleomycin family |
| 09/02/2004 | WO2004045371A3 Methods for diagnosing the presence or stage of cancer |
| 09/02/2004 | WO2004042870A3 Cartridge for packaging a sensor in a fluid calibrant |
| 09/02/2004 | WO2004038724A3 Sensor for tagged magnetic bead bioassays |
| 09/02/2004 | WO2004038422A3 Inhibitors of src kinase for use in alzheimer's disease |
| 09/02/2004 | WO2004036258A3 Screening antibodies using an optical fiber array device capable of simultaneously performing multiple functional assays |
| 09/02/2004 | WO2004036224A3 Screening method |
| 09/02/2004 | WO2004036207A3 Environmental control system fluid sensing system and method comprising a sesnsor with a mechanical resonator |
| 09/02/2004 | WO2004027040A3 Devices and methods for isolating and recovering target cells |
| 09/02/2004 | WO2004024084A3 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 09/02/2004 | WO2004022702A3 Methods and reagents for identifying inhibitors of viral protease activity. |
| 09/02/2004 | WO2004020666A3 Diagnostic and therapeutic use of thyroid hormone binding protein for neurodegenerative diseases |
| 09/02/2004 | WO2004020665A3 Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases |
| 09/02/2004 | WO2004020456A3 Selecting therapeutic human monoclonal antibodies from disease-specific libraries |
| 09/02/2004 | WO2004016765A3 Method for search based character optimization |
| 09/02/2004 | WO2004016212A3 Methods and compositions for targeting secretory lysosomes |
| 09/02/2004 | WO2004010101A3 Detection of chemical ligation using fluorescence quenching leaving groups |
| 09/02/2004 | WO2004008137A3 Diagnosis and therapy of breast tumours resistant to antiestrogen treatment |
| 09/02/2004 | WO2004008102A3 Liver tumor marker sequences |
| 09/02/2004 | WO2003105763B1 Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof |
| 09/02/2004 | WO2003093817A3 Method of identifying ligands for nuclear receptors |
| 09/02/2004 | WO2003092601A3 A method for detecting lysosomal storage diseases |
| 09/02/2004 | WO2003091421A3 Methods and systems for the prediction of the biological function of biopolymers |
| 09/02/2004 | WO2003087843A3 Diagnostics and therapeutics for diseases associated with mas related gene f (mrgf) |
| 09/02/2004 | WO2003083440A3 Methods and compositions for detection and quantitation of nucleic acid analytes |
| 09/02/2004 | WO2003076932A3 Novel method for detecting and analyzing protein interactions in vivo |
| 09/02/2004 | WO2003072122A3 Diagnostics and therapeutics for diseases associated with endothelial differentiation lysophosphatic acid g-protein-coupled receptor 7 (edg7) |
| 09/02/2004 | WO2003070967A3 Highly homogeneous molecular markers for electrophoresis |
| 09/02/2004 | WO2003067239A3 Bio-sensors |
| 09/02/2004 | WO2003048302A3 Identifying anti-tumor targets or agents by lipid raft immunization and proteomics |
| 09/02/2004 | WO2003015697A3 Interleukin-2 mutants with reduced toxicity |
| 09/02/2004 | US20040172230 Computer system and method for calculating a pharmacokinetic behavior of a chemical substance in insects |
| 09/02/2004 | US20040172200 Constellation mapping and uses thereof |
| 09/02/2004 | US20040172000 Disposable article having a biosensor |
| 09/02/2004 | US20040171968 Analyzing apparatus, piercing element integrally installed body for temperature measuring device with analyzing apparatus, and body fluid sampling apparatus |
| 09/02/2004 | US20040171816 Humanized antibodies that recognize beta amyloid peptide |
| 09/02/2004 | US20040171815 treatment of diseases associated with amyloid deposits in the brain (pre-clinical Alzheimer's disease or Down's syndrome); genetic engineering |
| 09/02/2004 | US20040171811 for drug screening using animal models with in vitro activation; genetic engineering |
| 09/02/2004 | US20040171808 by reacting a reactive functional group present at the free terminal of the water-soluble polymer compound chain which is bonded at a binding terminal thereof in the manner of bristles of a brush onto a surface of a base material; |
| 09/02/2004 | US20040171806 Modified hpv e6 and e7 genes and proteins useful for vaccination |
| 09/02/2004 | US20040171804 for drug screening cancer, osteoporosis, obesity, Alzheimer's disease drugs; genetic engineering; kits |
| 09/02/2004 | US20040171801 Nk-2 homeobox transcription factor |
| 09/02/2004 | US20040171771 Core-shell type particle having signal-generating susbstance enclosed therein and process for producing the same |
| 09/02/2004 | US20040171541 combination comprising a polypeptide comprising the modulating sequence of the erythropoietin receptor and a non-peptide organic molecule in the treatment of anemia |
| 09/02/2004 | US20040171523 Immunogenic glycopeptides, screening, preparation and uses |
| 09/02/2004 | US20040171517 Compounds and methods for modulating bacterial functions |
| 09/02/2004 | US20040171176 Stable carrier particle latex for use in immunoserological testing |
| 09/02/2004 | US20040171175 can be employed in sensors suitable for the ultra-sensitive detection of bacterial/viral pathogens, cancer; solid phase synthesis |
| 09/02/2004 | US20040171174 Diagnostic detection device and method |
| 09/02/2004 | US20040171173 Device for collecting liquid samples |
| 09/02/2004 | US20040171172 Method and apparatus for qualitative and quantitative detection of analytes |
| 09/02/2004 | US20040171168 Inspection pretreatment method and inspection pretreatment system of bovine spongiform encephalopathy |
| 09/02/2004 | US20040171166 Method and apparatus for performing microassays |
| 09/02/2004 | US20040171164 Method for measurement of immature granulocytes |
| 09/02/2004 | US20040171163 Electrical conductive containment system |
| 09/02/2004 | US20040171143 Nanoporous silicon bioreactor |
| 09/02/2004 | US20040171142 Method for producing a plurality of identical copies of a two-dimensional test array of probe molecules |
| 09/02/2004 | US20040171141 Transport container for slides for immunological labeling for thin tissue sections |
| 09/02/2004 | US20040171137 Method and apparatus for detecting the presence of microbes and determining their physiological status |
| 09/02/2004 | US20040171122 Gm-csf and/or defensin protein expression regulators in epithelial cells comprising ets transcription factor or gene encoding the same |
| 09/02/2004 | US20040171120 Enhanced insecticidal protein for killing bettles, moths, flies; biolgical pest control |
| 09/02/2004 | US20040171113 Antigens of group b streptococcus and corresponding dna fragments |
| 09/02/2004 | US20040171111 Polypeptide of a p53 protein-specific murin a/t-cell receptor, nucleic acids coding therefor and use thereof |
| 09/02/2004 | US20040171110 Novel member of the lysyl oxidase gene family |
| 09/02/2004 | US20040171107 Modified flourescent proteins |
| 09/02/2004 | US20040171102 Apparatus and method for immunological labeling for thin tissue sections |
| 09/02/2004 | US20040171100 Method of detecting inorganic phosphoric acid, pyrophosphate and nucleic acid, and method of typing SNP sequence of DNA |
| 09/02/2004 | US20040171099 Using luciferin derivatives for analyzing metabolic activity in animals, cells or in cell-free reaction formulations |
| 09/02/2004 | US20040171098 Signalling compounds for use in methods of detecting hydrogen peroxide |
| 09/02/2004 | US20040171096 Using lipid phosphates activity profile as diagnostic tool for detection and treatment of cancer; pregnancy determination; kits |
| 09/02/2004 | US20040171095 Using presence of prostaglandin D synthase (PGDS) in milk as indicator of mammary gland inflammation in milk cows; veterinary medicine |
| 09/02/2004 | US20040171093 Methods for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses |
| 09/02/2004 | US20040171092 Compensation for variability in specific binding in quantitative assays |
| 09/02/2004 | US20040171091 Standardized evaluation of therapeutic efficacy based on cellular biomarkers |
| 09/02/2004 | US20040171090 Screening for cytotoxic t-lymphocyte recognition antigen associated with human t-cell leukemia virus infected cells for diagnosing and prognosing inflammation and cell proliferation disorders |
| 09/02/2004 | US20040171089 High-throughput screening assay for identifying substances capable of modulating cell survival and/or proliferation |
| 09/02/2004 | US20040171088 Determining white blood cell concentration using immunoglobulin imaging of elastase; cytometry; immunoassay |
| 09/02/2004 | US20040171087 Quantitative single-step immunoassay in lyophilized form |
| 09/02/2004 | US20040171086 Selective modulation of TLR-mediated biological activity |
| 09/02/2004 | US20040171085 Identifying modulator which inteferes with binding of ubiquitin and polypeptide comprising ubiquitin binding motif fo treatment and prevention of nervous system disorders; neuroprotectants |
| 09/02/2004 | US20040171084 Screening compound libraries using an optical fiber array device capable of simultaneously performing multiple functional assays |
| 09/02/2004 | US20040171083 Polymorphisms of the 5' region of the human 5-HT1A gene, associated proteins of the 5' region and a diagnostic test for major depression and related mental illnesses |
| 09/02/2004 | US20040171082 Diagnostic method |
| 09/02/2004 | US20040171081 Identifying immunodominant epitope for elliciting immune response to treat and prevent tumors and infections; immunotherapy |
| 09/02/2004 | US20040171080 Method of assaying for agonists or antagonist of dynorphin a binding to the mas receptor |
| 09/02/2004 | US20040171078 Lipoprotein fingerprinting methods using metal ion chelate salts |
| 09/02/2004 | US20040171076 Homogeneously mixed rare-earth doped beads and labeled particle for use as tools in detection of biomolecules; biological and chemical assays for monitoring food and water quality control; genomics |
| 09/02/2004 | US20040171075 Modulation of protein functionalities |
| 09/02/2004 | US20040171074 Structures of substrate binding pockets of SCF complexes |
| 09/02/2004 | US20040171073 Modulators which prevent lipid transport via blocking activity of scavenger receptors and for treating atheroscerotic disosrders; contraceptives |
| 09/02/2004 | US20040171071 Diagnosing spongiform encephalopathies via presence of viral peptide/glycoprotein complexes in tissues; neurodegenerative diseases |
| 09/02/2004 | US20040171070 Peptide analysis using a solid support |
| 09/02/2004 | US20040171069 Kinetic assay |